Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
07/05/2000 | EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
07/05/2000 | EP0565621B1 Method of making camptothecin and camptothecin analogs |
07/05/2000 | CN1259123A Method for the production of 2,6-dichloro-5-fluoronicotinonitrile and the chemical compound 3-cyano-2-hydroxy-5-fluoropyride-6-one-monosodium salt and its tautomers |
07/05/2000 | CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use |
07/05/2000 | CN1259118A Organic compound |
07/05/2000 | CN1259017A Non-spherical and non-platelet pyrithione salts |
07/05/2000 | CN1258674A Pyrone carboxylic acid derivate or its salt and antibiotic with the same as effective component |
07/05/2000 | CN1258672A Amino-compound |
07/04/2000 | US6084120 β-Alkoxyacrylates against malaria |
07/04/2000 | US6084105 Cyclization in the presence of a base a 2-arylhydrazino-succinonitrile compound to produce a 5-amino-1-aryl-3-cyano-pyrazole pesticide intermediate |
07/04/2000 | US6084101 Raw materials for dyes, pigments and photosensitive compounds; 2-hydroxy-3(6)-heterocyclylamido-3,(6)-metoxycarbonylnaphthalenes |
07/04/2000 | US6083991 Anti-arrhythmic composition and methods of treatment |
07/04/2000 | US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant |
07/04/2000 | US6083964 Antiepileptic pharmaceutical compositions with no neurotoxicity |
07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |
07/04/2000 | US6083955 Having a high affinity for drugs, especially endoserine receptors |
07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
07/04/2000 | US6083938 Pyridinylbisphosphonates for use as a therapeutical agent |
07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
07/04/2000 | CA1341047C 4-(n-benzyl-n-methylamino) pyridine acid salts and use in preparation of polymer-supported catalysts |
07/04/2000 | CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents |
06/29/2000 | WO2000037446A1 Method for producing heteroaromatic aldehydes |
06/29/2000 | WO2000037438A1 Novel thio-aminotetralin compounds useful in pain management |
06/29/2000 | WO2000037434A1 Amide derivatives |
06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
06/29/2000 | WO2000037428A1 Process for the preparation of aromatic carboxylic acid amides |
06/29/2000 | WO2000037422A2 Ion channel modulating agents |
06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
06/29/2000 | WO2000012472A3 Process for preparing certain phenyl urea compounds |
06/29/2000 | WO2000002887A3 Ligands for metals and metal-catalyzed processes |
06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
06/29/2000 | DE19918021C1 Preparation of chlorinated pyridine sulfonic acid chloride derivatives from hydroxypyridine sulfonic acids and phosphorus trichloride/chlorine gas; useful as intermediates for drugs, e.g. torasemide |
06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
06/28/2000 | EP1013647A2 Process for the preparation of N-(amino-4,6-dihalogenopyrimidin)-formamides |
06/28/2000 | EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit |
06/28/2000 | EP1013636A1 Preparation of allylic aromatic compounds |
06/28/2000 | EP1012892A1 Electroluminescent device |
06/28/2000 | EP1012144A1 Method for producing (hetero)aromatic hydroxylamines |
06/28/2000 | EP1012142A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2 |
06/28/2000 | EP1012141A1 Supernucleophilic 4-substituted-pyridine catalysts, and processes useful for preparing same |
06/28/2000 | CN1258301A Antiviral protease inhibitors |
06/28/2000 | CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them |
06/28/2000 | CN1258280A Cyanoamidines as cell proliferation inhibitors |
06/28/2000 | CN1258279A Cyanoguanidines as cell proliferation inhibitors |
06/28/2000 | CN1258278A Cyanoguanidines as cell proliferation inhibitors |
06/28/2000 | CN1258277A Cyanoguanidines as cell proliferation inhibitors |
06/28/2000 | CN1258276A Cyanoguanidines as cell proliferation inhibitors |
06/28/2000 | CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them |
06/28/2000 | CN1053899C Acylguanidine, its preparation process and use, and pharmaceutical composition contg. same |
06/28/2000 | CN1053895C Substd. sulfonic acid amide, preparation process and pharmaceutical composition of same |
06/28/2000 | CN1053894C Process for preparing 4,4'-bipyridyl |
06/27/2000 | US6080867 Imidation and cyclization to form a chemical intermediate for making highly potent, environmentally benign, imidazoline herbicidal agents |
06/27/2000 | US6080866 A chemical intermediates for endothelin receptor antagonists |
06/27/2000 | US6080839 Labeling reactants and their use |
06/27/2000 | US6080790 Selective and potent inhibitors of phosphodiesterase iv and are useful for the prophylaxis and treatment of inflammatory diseases and the alleviation of conditions associated with central nervous malfunction |
06/27/2000 | US6080784 A phorbol derivative used as antiinflammatory agent |
06/27/2000 | US6080773 Benzylamine derivatives which are useful in treating psychiatric disorders |
06/27/2000 | US6080768 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
06/27/2000 | US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
06/27/2000 | US6080766 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation |
06/27/2000 | CA2188427C Neurotransmitter release enhancers |
06/27/2000 | CA2180000C Amino-acid amide derivatives, method for producing the same, and agricultural or horticultural fungicides |
06/22/2000 | WO2000036054A1 Ferroelectric active matrix displays with wide operating temperature range |
06/22/2000 | WO2000035882A1 1,2,3,4-tetrahydronaphthalenes and their pharmaceutical use |
06/22/2000 | WO2000035867A1 Novel ligands of nuclear receptor |
06/22/2000 | WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists |
06/22/2000 | WO2000035859A1 Substituted aryl and heteroaryl derivatives, their production and their use as medicines |
06/22/2000 | WO2000035858A1 Phenylglycine derivatives |
06/22/2000 | WO2000035855A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4 |
06/22/2000 | WO2000035442A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
06/22/2000 | WO2000035436A2 Treatment of arthritis with mek inhibitors |
06/22/2000 | WO2000035435A1 Use of a mek inhibitor for preventing transplant rejection |
06/22/2000 | WO2000035430A2 Homer a new target of treating psychiatric disorders |
06/22/2000 | CA2355890A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists |
06/22/2000 | CA2355299A1 Novel ligands of nuclear receptor |
06/22/2000 | CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
06/22/2000 | CA2354323A1 Homer a new target of treating psychiatric disorders |
06/22/2000 | CA2353151A1 Substituted aryl and heteroaryl derivatives, the preparation thereof and their use as medicaments |
06/22/2000 | CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4 |
06/22/2000 | CA2346684A1 Use of a mek inhibitor for preventing transplant rejection |
06/22/2000 | CA2346448A1 Treatment of arthritis with mek inhibitors |
06/21/2000 | EP1010692A1 Liquid-crystal compounds having large value of permittivity anisotropy, liquid-crystal composition containing the same, and liquid-crystal display element made using the liquid-crystal composition |
06/21/2000 | EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them |
06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
06/21/2000 | EP1009736A1 Malonic acid based matrix metalloproteinase inhibitors |
06/21/2000 | EP1009729A1 Halogenated acrylates and polymers derived therefrom |
06/21/2000 | EP1009402A4 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
06/21/2000 | EP1009402A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
06/21/2000 | DE19858029A1 New substituted (hetero)aryl-alkanes, used as thrombin inhibitors, serine protease inhibitors, antithrombotic agents and intermediates |
06/21/2000 | CN1257484A Synthesis of intermediates useful in preparing tricyclic compounds |
06/21/2000 | CN1257481A Novel pyridine derivatives and pharmaceutical compositions containing them |
06/21/2000 | CN1257473A New polymerisable liquid crystalline compounds |
06/21/2000 | CN1053658C Aminostilbazole derivative and medicine |
06/21/2000 | CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof |
06/20/2000 | US6077957 Process for the preparation of nicotinic acid |
06/20/2000 | US6077954 Substituted heterocyclic compounds |
06/20/2000 | US6077856 Hemoregulatory compounds |
06/20/2000 | US6077855 Hemoregulatory compounds |
06/20/2000 | US6077854 Tri-substituted phenyl derivatives and processes for their preparation |